Fuller & Thaler Asset Management, Inc. Horizon Therapeutics Public LTD CO Transaction History

Fuller & Thaler Asset Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$91.91 - $110.37 $93,840 - $112,687	-1,021 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $2.96 Million - $3.94 Million	-41,243 Reduced 97.58%	1,021 $94,000
Q4 2020 Feb 11, 2021	SELL	$67.0 - $84.39 $4,020 - $5,063	-60 Reduced 0.14%	42,264 $3.09 Million
Q3 2020 Nov 09, 2020	SELL	$55.23 - $79.93 $11.1 Million - $16.1 Million	-201,304 Reduced 82.63%	42,324 $3.29 Million
Q2 2020 Aug 13, 2020	SELL	$30.2 - $56.98 $24.2 Million - $45.6 Million	-800,893 Reduced 76.68%	243,628 $13.5 Million
Q1 2020 May 06, 2020	SELL	$24.87 - $38.56 $1.55 Million - $2.41 Million	-62,517 Reduced 5.65%	1,044,521 $30.9 Million
Q4 2019 Feb 14, 2020	BUY	$25.43 - $36.67 $1.13 Million - $1.63 Million	44,348 Added 4.17%	1,107,038 $40.1 Million
Q3 2019 Nov 13, 2019	BUY	$23.0 - $27.97 $8.63 Million - $10.5 Million	375,407 Added 54.62%	1,062,690 $28.9 Million
Q2 2019 Aug 13, 2019	BUY	$22.81 - $28.48 $15.7 Million - $19.6 Million	687,283 New	687,283 $16.5 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.